Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stage IA Uterine Sarcoma 1 Ependymoma 1 Anus Neoplasms 1

Interventions

Temozolomide 26 Magnetic Resonance Spectroscopy 19 Etoposide 14 Cyclophosphamide 13 Radiotherapy 11 Filgrastim 10 Bevacizumab 10 Carboplatin 9 Biopsy 8 Cisplatin 7 X-Rays 6 Thiotepa 6 Specimen Handling 6 Phantoms, Imaging 6 Carmustine 6 Radiation 5 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Irinotecan 5 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5 sargramostim 4 Vincristine 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 Erlotinib Hydrochloride 4 Azacitidine 4 olaparib 3 etoposide phosphate 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ependymoma × Linear Energy Transfer × Clear all

NCT03750513 2026-05-20

LET Optimized IMPT in Treating Pediatric Patients With Ependymoma

M.D. Anderson Cancer Center

Phase 1 Recruiting

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡